Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines
Open Access
|Dec 2008References
- A. B. A. El-Gazzar, M. M. El-Enany and M. N. Mahmoud, Synthesis, Analgesic, anti-inflammatory and antimicrobial activity of some novel pyrimido[4,5-]quinolin-4-ones,16 (2008) 3261-3273; DOI: 10.1016/j.bmc.2007.12.012.
- D. H. Boschelli, Z. Wu, S. R. Klutchko, H. D. Showalter, J. M. Hamby, G. H. Lu, T. C. Major, T. K. Dahring, B. Batley, R. L. Panek, J. Keiser, B. G. Hartl, A. J. Kraker, W. D. Klohs, B. J. Roberts, S. Patmore, W. L. Elliott, R. Steinkampf, L. A. Bradford, H. Hallak and A. M. Doherty, Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8-pyrido[2,3-]pyrimidines: identification of potent selective platelet-derived growth factor receptor tyrosine kinase inhibitors,41 (1998) 4365-4377; DOI: 10.1021/jm980398y 50022-2623(98)00398-7.
- S. R. Natarajan, D. D. Wisnoski, J. E. Thompson, E. A. O'Neill and S. J. O'Keefe, p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-]pyrimidin-2-ones,16 (2006) 4400-4404; DOI: 10.1016/j.bmcl. 2006.05.045.
- C. B. Vu, G. P. Luke, N. Kawahata, W. C. Shakespeare, Y. Wang, R. Sundara-Moorthi, C. A. Metcalf, T. P. Keenan, S. Pradeepan, E. Corpuz, T. Merry, R. S. Bohacek, D. C. Dalgarno, S. S. Narula, M. R. van Schravendijk, M. K. Ram, S. Adams, S. Liou, J. A. Keats, S. M. Violette, W. Guan, M. Weigele and T. K. Sawyer, Bone-targeted pyrido[2,3-]pyrimidin-7-ones: potent inhibitors of src tyrosine kinase as novel antiresorptive agents,13 (2003) 3071-3074; DOI: 10.1016/S0960-894X(03)00649-8.
- A. J. Kraker, B. G. Hartl, A. M. Amar, M. R. Barvian, H. D. Hollis Showalter and C. W. Moore, Biochemical and cellular effect of c-Src kinase-selective pyrido[2,3-]pyrimidine tyrosine kinase inhibitors,60 (2000) 885-898.
- M. Barvian, R. J. Booth, J. Quin III., J. T. Repine, D. J. Sheehan, P. L. Toogood, S. N. Vanderwel and H. Zhou, 2-(-d], PCT. Int. Appl. (2007), (C07D401/14; A61K31/444) WO 7208489.
- H. B. Arzeno, J. J. Chen, J. P. Dunn, D. M. Goldstein and J. A. Lim, Preparation of 7-oxopyridopyrimidines as P38 MAP kinase inhibitors, PCT. Int. Appl. (2002), WO 200218379.
- R. J. Booth, A. Chatterjee and T. C. Malone, Pyridopyrimidinone derivatives for treatment of neurodegenerative disease, PCT. Int. Appl. (2001), WO 2001055148.
- S. Tu, J. Zhang, X. Zhu, J. Xu, Y. Zhang, Q. Wang, R. Jia, B. Jiang and J. Zhang, New potential inhibitors of cyclin-dependent kinase: Design and synthesis of pyrido[2,3-]pyrimidine derivatives under microwave irradiation,16 (2006) 3578-3581; DOI: 10.1016/j. bmcl.2006.03.084.
- M. Hájek, N. Matulová, I. Votruba, A. Holý and E. Tlouš'tova, Inhibition of human, telomerase by diphosphates of acyclic nucleoside phosphonates,70 (2005) 894-900; DOI: 10.1016/j.bcp.2005.06.07.
- J. J. Chen, J. P. Dunn, D. M. Goldstein and C. M. Stahl, Preparation of 2,6-disubstituted 7-oxopyrido[2,3-]pyrimidines for treating P38 mediated disorders, PCT. Int. Appl. (2002) WO 2002064594.
- S. R. Kanth, G. V. Reddy, K. H. Kishore, P. S. Rao, B. Narsaiah and U. S. N. Murthy, Convenient synthesis of novel 4-substituted amino-5-trifluoromethyl-2,7-disubstituted pyrido[2,3-] pyrimidines and their antibacterial activity,41 (2006) 1011-1016; DOI: 10.1016/j.ejmech. 2006.03.028.
- V. Darias, S. S. Abdallah, M. L. Tello, L. D. Delgado and S. Vega, NSAI activity study of 4-phenyl-2-thioxo-benzo[4,5]thieno[2,3-]pyrimidines derivatives,327 (1994) 779-383; DOI: 10.1002/ardp. 19943271205.
- L. Cordeu, E. Cubedo, E. Bandres, A. Rebollo, X. Saenz, H. M. Chozes, V. Dominquez, M. Echeverria, B. Mendivil, C. Sanmartin, J. A. Palop, M. Font and J. Garcia-Foncillas, Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-]-pyrimidine derivatives,15 (2007) 1659-1669; DOI: 10.1016/j.bmc.2006.12.010.
- M. Zink, H. Lanig and R. Troschütz, Structural variations of piritrexim, a lipophilic inhibitor of human dihydrofolate reductase: synthesis, antitumor activity and molecular modeling investigations,39 (2004) 1079-1088; DOI: 10.1016/j.ejmech.2004.09.001.
- R. A. Newberry and B. J. Bushell, Thiazole derivatives U.S. 3, 979, 402 (Cl.260-302R; Co7 D227122). 07 Sep. (1976), Brit. Appl. 748, 870, 27 Feb. (1974); ref.86 (1977) 29795z.
- M. Yu. Gavrilov, L. G. Mardanova, V. E. Kolla and M. E. Konshin, Synthesis and anti-inflammatory and analgesic activities of 2-arylamino-5,6,7,8-tetrahydroquinoline-3-carboxamides,22 (1988) 554-556; DOI: 10.1007/BF00763528.
- A. B. A. El-Gazzar, A. M. Gaafar, H. N. Hafez and A. M. Abdel-Fattah, Regioselective synthesis and reactions of polynuclear heterocyclic derived from pyrido[2,3-]pyrimidines, with new ring system,182 (2007) 369-403; DOI: 10.1080/10426500600919967.
- (Eds. E. D. Olfert, B. M. Cross and A. A. McWilliam), 2ed, Vol. I, Canadian Council on Animal Care, Ottawa 1993, p. 211.
- C. A. Winter, E. A. Risley and G. W. Nuss, Carragenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs,111 (1962) 544-547.
- O. O. Adeyemi, O. S. Okpo and O. J. Okpaka. The analgesic effect of the methanolic extract of acanthus montanus,90 (2004) 45-48; DOI: 10.1016/j.jep.2003.09.021.
- V. Cioli, S. Putzolu, V. Rossi, S. P. Barrcellona and C. Corradino, The role of direct tissue contact in the production of gastro-intestinal ulcers by anti-inflammatory drugs in rats,50 (1979) 283-289.
Language: English, Croatian
Page range: 359 - 378
Published on: Dec 22, 2008
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2008 Hend Hafez, Hebat-Allah Abbas, Abdel-Rahman El-Gazzar, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.